FDMT
USD4D Molecular Therapeutics Inc. Common Stock
Preço em tempo real
Gráfico de preços
Métricas-chave
Métricas de mercado
Abertura
$11.020
Máximo
$11.020
Mínimo
$10.040
Volume
0.63M
Fundamentos da empresa
Capitalização de mercado
578.4M
Setor
Biotecnologia
País
United States
Estatísticas de negociação
Volume médio
0.80M
Bolsa de valores
NMS
Moeda
USD
Faixa de 52 semanas
Notícias relacionadas
4DMT Announces Exclusive License Agreement with Otsuka Pharmaceutical Co., Ltd. for Development and Commercialization of 4D-150 in Asia-Pacific
4DMT to receive $85 million upfront cash payment and expect to receive at least $50 million of cost sharing from Otsuka over the next three years for development activities supporting global registration Up to $336
RBC Capital Reiterates Outperform on 4D Molecular Therapeutics, Maintains $26 Price Target
RBC Capital analyst Lisa Walter reiterates 4D Molecular Therapeutics with a Outperform and maintains $26 price target.
4DMT to Participate in Chardan's 9th Annual Genetic Medicines Conference
EMERYVILLE, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (NASDAQ:FDMT, 4DMT or the Company)), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with
Ações relacionadas
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.